换一批Toward phase contribution assessment in perioperative oncology:insights from NSCLC and a proposal for broader implementation
摘要Dear Editor,On July 25,2024,an Oncologic Drugs Advisory Committee meeting was held to discuss the design of the AEGEAN trial,which evaluated the perioperative use of durvalumab for resectable non-small cell lung cancer(NSCLC)[1].
更多相关知识
栏目名称
DOI
10.1186/s40779-025-00622-2
发布时间
2026-04-15（万方平台首次上网日期，不代表论文的发表时间）
- 浏览1
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
